Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
GLP-1s are more than just weight loss drugs. They're a chance to rewrite our evolutionary story, to take control of our biology in a way never before possible.

With public understanding divided on the causes of obesity, this paper aims to transcend the debate between personal responsibility and disease status to offer a fresh perspective – that obesity is an evolutionary trap. Specifically, it examines:
- Why human biology creates an inherent vulnerability to obesity
- How amplifying our natural GLP-1 levels can address multiple different diseases
- The current status of GLP-1 drug approvals by condition
- The unprecedented questions we now face about equity, access & our collective future